Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Semin Respir Crit Care Med ; 40(2): 271-277, 2019 04.
Article in English | MEDLINE | ID: mdl-31137065

ABSTRACT

In 2015, a multidisciplinary task force comprising pulmonologists, rheumatologists, pathologists, and radiologists representing the European Respiratory Society and American Thoracic Society published a diagnostic classification schema for individuals with interstitial lung disease and autoimmune features who did not meet criteria for a defined connective tissue disease. The term interstitial pneumonia with autoimmune features (IPAF) was applied. Classification criteria are often nonspecific, but up to 90% of subjects with IPAF have serological evidence for autoimmunity (particularly (+) antinuclear antibodies). Distinguishing patients with IPAF from idiopathic pulmonary disorders may be difficult. The natural history and appropriate management of IPAF have not been clarified, as data are largely limited to retrospective studies. In this review, we discuss the salient clinical, serologic, histologic, and radiographic features of IPAF and discuss an approach to management.


Subject(s)
Autoimmunity , Lung Diseases, Interstitial/immunology , Undifferentiated Connective Tissue Diseases/immunology , Humans , Lung Diseases, Interstitial/classification , Lung Diseases, Interstitial/complications , Lung Diseases, Interstitial/diagnosis , Undifferentiated Connective Tissue Diseases/complications , Undifferentiated Connective Tissue Diseases/diagnosis
2.
Biol Psychiatry ; 76(1): 8-14, 2014 Jul 01.
Article in English | MEDLINE | ID: mdl-24199666

ABSTRACT

BACKGROUND: Although considerable evidence implicates dopamine D1-receptor signaling in the nucleus accumbens in motivation for cocaine during early stages of addiction, less is known with regard to its role after the development of addiction. Here, we examined its role in the development of an addicted phenotype in intact male and female rats, and in female rats that were either resistant or vulnerable to developing this phenotype. METHODS: Intact males, females, and ovariectomized (OVX) females with and without estradiol (vulnerable, OVX+E; resistant, OVX+Veh) were given either short access (ShA) (three fixed-ratio 1 sessions, maximum of 20 infusions) or 24-hour extended access (ExA) to cocaine for 10 days (4 trials/hour). Motivation for cocaine was assessed after a 14-day abstinence period with a progressive-ratio schedule. Once responding stabilized, the effects of intra-accumbens infusion of the D1-receptor antagonist, SCH-23390 (0, .3, 1.0, 3.0 µg), were examined. RESULTS: Motivation for cocaine was markedly higher after abstinence from ExA versus ShA self-administration in intact males and females, indicating the development of an addicted phenotype in these groups. Motivation for cocaine was also higher than ShA control subjects in OVX+E but not OVX+Veh females after ExA self-administration, confirming the categorization of these groups as vulnerable versus resistant. After ExA self-administration, intact males and females and OVX+E but not OVX+Veh females were less sensitive to the effects of D1-receptor antagonism as compared with their ShA counterparts. CONCLUSIONS: These results suggest that the role of D1-receptor signaling, although critical in "nonaddicted" stages, becomes diminished once addiction has developed.


Subject(s)
Behavior, Addictive/physiopathology , Cocaine-Related Disorders/physiopathology , Nucleus Accumbens/physiology , Receptors, Dopamine D1/physiology , Animals , Benzazepines/administration & dosage , Benzazepines/pharmacology , Cocaine/administration & dosage , Conditioning, Operant/drug effects , Dopamine Antagonists/administration & dosage , Dopamine Antagonists/pharmacology , Estradiol/pharmacology , Female , Male , Microinjections , Nucleus Accumbens/drug effects , Ovariectomy , Phenotype , Rats , Reinforcement Schedule , Self Administration
SELECTION OF CITATIONS
SEARCH DETAIL
...